We work on drug discovery by combining our proprietary global top level antibody engineering and cyclic peptide technology and biological hypothesis of disease causing mechanism to solve the unmet medical needs.

Sweeping Antibody®

The Sweeping Antibody® is a recycling antibody that has been further engineered to bind to Fc receptor to enhance the cellular uptake of antibody-antigen complex. This allows antibody to not only bind to the target antigen in plasma but also enables antibody to eliminate or remove the antigen from plasma which cannot be achieved by conventional antibodies. Our first Sweeping Antibody® is, GYM329, is now being tested in clinical study, and we have multiple Sweeping Antibody® projects in the drug discovery stage.

Sweeping Antibody® is a registered trademark of Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan)

Reference Article:

Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering

J Immunol. 2015 Oct 1;195(7):3198-205

< Back